Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sheikh Mohammad Umar

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Asian Pacific Journal of Cancer Prevention : APJCP|July 28, 2021
Dihydrotanshinone-I modulates Epithelial Mesenchymal Transition (EMT) Thereby Impairing Migration and Clonogenicity of Triple Negative Breast Cancer CellsAkanksha Kashyap, Sheikh Mohammad Umar, Arundhathi Dev J R, et al.
Nutrition and Cancer|July 19, 2021
Quercetin Impairs HuR-Driven Progression and Migration of Triple Negative Breast Cancer (TNBC) CellsSheikh Mohammad Umar, Sushmita Patra, Akanksha Kashyap, et al.
Cell Biology International|May 22, 2024
7-amino carboxycoumarin 2 inhibits lactate induced epithelial-to-mesenchymal transition via MPC1 in oral and breast cancer cellsSheikh Mohammad Umar, Arundhathi J R Dev, Akanksha Kashyap, et al.
Technology in Cancer Research & Treatment|February 17, 2026
β-Catenin-Facilitated Glycolytic Reprogramming Fuels TNBC Progression: Therapeutic Blockade with XAV939Sheikh Mohammad Umar, Shruti Kahol, Sandeep R Mathur, et al.
Experimental Cell Research|September 13, 2020
Prognostic and therapeutic relevance of phosphofructokinase platelet-type (PFKP) in breast cancerSheikh Mohammad Umar, Akanksha Kashyap, Shruti Kahol, et al.
Discover Oncology|May 11, 2026
Exploring the efficacy of XAV939 and LF3 in targeting β-catenin signalling in gallbladder cancer cell linesAkanksha Kashyap, Sheikh Mohammad Umar, Arundhathi J R Dev, et al.
Molecular Biology Reports|July 6, 2024
Canonical WNT/β-catenin signaling upregulates aerobic glycolysis in diverse cancer typesMeetu Rathee, Sheikh Mohammad Umar, Arundhathi J R Dev, et al.
International Journal of Biological Macromolecules|July 10, 2025
Biophysical and molecular characterization of HuR inhibitors, CMLD-2 and Dihydrotanshinone I (DHTS), in Triple Negative Breast Cancer (TNBC)Arundhathi J R Dev, Lakshay Malhotra, Akanksha Kashyap, et al.
Journal of Cellular Biochemistry|July 14, 2023
Combination of 3PO analog PFK15 and siPFKL efficiently suppresses the migration, colony formation ability, and PFK-1 activity of triple-negative breast cancers by reducing the glycolysisAkanksha Kashyap, Sheikh Mohammad Umar, Arundhathi Dev J R, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Asian Pacific Journal of Cancer Prevention : APJCP|July 28, 2021
Dihydrotanshinone-I modulates Epithelial Mesenchymal Transition (EMT) Thereby Impairing Migration and Clonogenicity of Triple Negative Breast Cancer CellsAkanksha Kashyap, Sheikh Mohammad Umar, Arundhathi Dev J R, et al.
Nutrition and Cancer|July 19, 2021
Quercetin Impairs HuR-Driven Progression and Migration of Triple Negative Breast Cancer (TNBC) CellsSheikh Mohammad Umar, Sushmita Patra, Akanksha Kashyap, et al.
Cell Biology International|May 22, 2024
7-amino carboxycoumarin 2 inhibits lactate induced epithelial-to-mesenchymal transition via MPC1 in oral and breast cancer cellsSheikh Mohammad Umar, Arundhathi J R Dev, Akanksha Kashyap, et al.
Technology in Cancer Research & Treatment|February 17, 2026
β-Catenin-Facilitated Glycolytic Reprogramming Fuels TNBC Progression: Therapeutic Blockade with XAV939Sheikh Mohammad Umar, Shruti Kahol, Sandeep R Mathur, et al.
Experimental Cell Research|September 13, 2020
Prognostic and therapeutic relevance of phosphofructokinase platelet-type (PFKP) in breast cancerSheikh Mohammad Umar, Akanksha Kashyap, Shruti Kahol, et al.
Discover Oncology|May 11, 2026
Exploring the efficacy of XAV939 and LF3 in targeting β-catenin signalling in gallbladder cancer cell linesAkanksha Kashyap, Sheikh Mohammad Umar, Arundhathi J R Dev, et al.
Molecular Biology Reports|July 6, 2024
Canonical WNT/β-catenin signaling upregulates aerobic glycolysis in diverse cancer typesMeetu Rathee, Sheikh Mohammad Umar, Arundhathi J R Dev, et al.
International Journal of Biological Macromolecules|July 10, 2025
Biophysical and molecular characterization of HuR inhibitors, CMLD-2 and Dihydrotanshinone I (DHTS), in Triple Negative Breast Cancer (TNBC)Arundhathi J R Dev, Lakshay Malhotra, Akanksha Kashyap, et al.
Journal of Cellular Biochemistry|July 14, 2023
Combination of 3PO analog PFK15 and siPFKL efficiently suppresses the migration, colony formation ability, and PFK-1 activity of triple-negative breast cancers by reducing the glycolysisAkanksha Kashyap, Sheikh Mohammad Umar, Arundhathi Dev J R, et al.
Pageof 1